rs3731249

Variant summary

Our verdict is Uncertain significance.
+2 Uncertain · Warm
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 2 classification points (ACMG Germline Pathogenicity v2019). PM2

The NM_000077.5(CDKN2A):c.442G>T (p.Ala148Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.A148= (synonymous): Likely_benign (ClinVar VariationId 921245, 2 stars); p.A148= (synonymous): Likely_benign (ClinVar VariationId 923208, 2 stars); p.A148P: Uncertain_significance (ClinVar VariationId 483343, 2 stars); p.A148T: Benign (ClinVar VariationId 41580, 2 stars); p.A148V: Uncertain_significance (ClinVar VariationId 231700, 2 stars)

Frequency

Genomes: not found (cov: 32)

Consequence

CDKN2A
NM_000077.5 missense

Scores

2
16

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.153

Publications

137 publications found
Variant links:
Genes affected
CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]
CDKN2A Gene-Disease associations (from GenCC):
  • melanoma, cutaneous malignant, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • melanoma-pancreatic cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, Ambry Genetics
  • familial atypical multiple mole melanoma syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • melanoma and neural system tumor syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000077.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 2 points.

PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (base 0.0001, raised to 0.00011 by highest known P/LP ClinVar AF 0.00011) — PM2 moderate.

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000077.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CDKN2A NM_000077.5
MANE Select
HGVSc / HGVSpc.442G>Tp.Ala148Ser
Exon rankExon 2 of 3
missense
Prot: NP_000068.1UniProt: K7PML8P42771-1
CDKN2A NM_058195.4
MANE Plus Clinical
HGVSc / HGVSpc.*86G>T
Exon rankExon 2 of 3
3_prime_UTR
Prot: NP_478102.2UniProt: Q8N726-1
CDKN2A NM_001195132.2
HGVSc / HGVSpc.442G>Tp.Ala148Ser
Exon rankExon 2 of 4
missense
Prot: NP_001182061.1UniProt: P42771-4

Ensembl Transcripts

CDKN2A ENST00000304494.10
TSL:1MANE Select
HGVSc / HGVSpc.442G>Tp.Ala148Ser
Exon rankExon 2 of 3
missense
Prot: ENSP00000307101.5UniProt: P42771-1
CDKN2A ENST00000498124.1
TSL:1
HGVSc / HGVSpc.442G>Tp.Ala148Ser
Exon rankExon 2 of 4
missense
Prot: ENSP00000418915.1UniProt: P42771-4
CDKN2A ENST00000579755.2
TSL:1MANE Plus Clinical
HGVSc / HGVSpc.*86G>T
Exon rankExon 2 of 3
3_prime_UTR
Prot: ENSP00000462950.1UniProt: Q8N726-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:31
GnomAD4 genome
Cov:32
TOPMed (Bravo)
AF: 0.00000378
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.00
AC:0
Hom:315
AN:706520
Showing 5 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Familial melanoma (1)
-
1
-
Hereditary cancer-predisposing syndrome (1)

Computational Scores

AlphaGenome AVI
Benign8.5
AlphaMissense
Benign0.087
BayesDel_addAF
Benign0.0038T
BayesDel_noAF
Benign-0.23
CADD
Benign10
DANN
Benign0.96
DEOGEN2
Benign0.10T
Eigen
Benign-0.98
Eigen_PC
Benign-1.0
FATHMM_MKL
Benign0.11N
FuncVEP CTI
Benign0.10
GPN-Star LLR
N/A-0.48
GPN-Star score
N/A0.48
LIST_S2
Benign0.73T
M_CAP
Benign0.052D
MetaRNN
Benign0.11T
MetaSVM
Benign-0.97T
Mutation Taster
N/A51/49polymorphism
PhyloP100
Benign0.15
popEVE
Benign-2.8
PrimateAI
Benign0.39T
PromoterAI
N/A-0.0061Neutral
PROVEAN
Benign-0.63N
REVEL
Uncertain0.29
Sift
Uncertain0.0080D
Sift4G
Benign0.097T
Varity_R
N/A0.11
VESM-3B
Benign-3.1
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.020
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.